INDIA approves 2 vaccines - Is their vaccine/rollout better than other countries?

TL;DR

The Indian government has approved two vaccines, Covishield and Covaxin, for their vaccination program, with Covishield being rolled out first. Both vaccines use different technologies and have their own advantages and similarities.

Transcript

hello guys uh this is uh dr palanipan manikam i'm going to make a quick video on the vaccination program in india indian government has approved both covaxen and kovi shield as a part of the vaccination program in this video we're going to see how that is different from the physio and modern vaccines are proved here in use what is the efficacy rate... Read More

Key Insights

• 🥶 mRNA vaccines like Pfizer and Moderna require very cold storage temperatures, making transportation difficult.
• 🍉 Long-term side effects of mRNA vaccines are still unknown due to their newness.
• 👍 The vaccines approved for India's program are Covishield (Oxford-AstraZeneca) and Covaxin (Bharat Biotech).
• 😒 Both vaccines use different technologies, with Covaxin being a virus-based vaccine and Covishield utilizing a modified adenovirus.
• ❓ Covishield is cheaper and more easily transportable compared to mRNA vaccines.
• ⏮️ Covaxin has a track record of success in previous vaccine programs for diseases like polio and hepatitis B.
• 🧑‍⚕️ India aims to vaccinate 300 million healthcare workers first, starting with Covishield.

Questions & Answers

Q: How do mRNA vaccines like Pfizer and Moderna work?

mRNA vaccines work by introducing genetic material that codes for spike proteins into the body, stimulating the production of antibodies against the spike proteins.

Q: What are the main problems with mRNA vaccines?

mRNA vaccines require extremely cold storage temperatures, are expensive, and have unknown long-term side effects due to being a new technology.

Q: How do Covishield and Covaxin work?

Covishield uses a modified adenovirus to stimulate the production of spike proteins, while Covaxin uses an inactivated virus to generate antibodies.

Q: Why was Covaxin approved before completing phase three trials?

Despite some political controversy, Bharat Biotech has a history of using similar vaccine technology without significant side effects.

Summary & Key Takeaways

• The Indian government has approved two vaccines, Covishield and Covaxin, for their vaccination program.

• Covishield is developed by Oxford University and distributed by the Serum Institute of India, while Covaxin is developed and made in India by Bharat Biotech.

• Covishield uses a modified adenovirus to stimulate the production of spike proteins, while Covaxin uses an inactivated virus to generate antibodies.